4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: May 22, 2019
Period of Report: May 20, 2019
Accession Number: 0001645470-19-000032

View Document ↗ View on SEC.gov ↗